Business Context and Reporting Period
This Form 8-K Current Report was filed by Herbalife Ltd. on June 25, 2024. The filing addresses a corporate governance update regarding the Board of Directors.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on personnel appointments and does not contain financial performance data.
Material Changes
The primary material change reported is the appointment of Perkins Miller as a director to fill a newly created Board seat on June 25, 2024. No committee assignments have been determined at the time of filing.
Guidance, Outlook, and Management Commentary
- Compensation: Mr. Miller's compensation will align with the Company's plan for non-employee directors as described in the Definitive Proxy Statement filed on March 12, 2024.
- Indemnification: Mr. Miller will enter into the Company's standard form of indemnification agreement.
- Related Party Transactions: The Company confirmed no arrangement or understanding existed for Mr. Miller's appointment and no material interest transactions involving him or his immediate family have occurred since the beginning of the last fiscal year.
Investor Verification Checklist
- Verify the specific committee assignments for Perkins Miller once disclosed in a future amendment.
- Review the Definitive Proxy Statement (Schedule 14A) filed on March 12, 2024, for details on non-employee director compensation.
- Confirm the total number of Board seats following this new appointment.